Pharmafile Logo

Adderall XR

China flag thumb

Roche drawn into Chinese probe into pharma

State authorities visit regional offices of Swiss company

China flag thumb

China targets UK exec in GSK corruption probe

Former GSK China manager Mark Reilly said to have ordered sales team to bribe doctors

Shire Basingstoke

Shire boosts rare disease portfolio with $260m Lumena deal

Acquisition of US company will bring two mid-stage candidates for rare liver diseases

- PMLiVE

GSK corruption claims extend to Jordan and Lebanon

Follows bribery allegations in Poland, China and Iraq

- PMLiVE

GSK under investigation in Poland for ‘camouflaged bribes’

A regional manager and 11 doctors have been charged, according to a BBC report

- PMLiVE

Pharma needs to be “revered by society”

Janssen’s Jane Griffiths and EFPIA chief Richard Bergstrom speak at eyeforpharma conference

- PMLiVE

Pharma companies back Rare Disease Day

Genzyme, Shire and more hold global campaigns today

The distressing impact of rare diseases

Much more needs to be done to address the problem of effective communications with stakeholders and adequate information for patients affected

- PMLiVE

A good reputation is more valuable than money

Putting patients at the heart of corporate culture is central to being a 'preferred partner'

- PMLiVE

EFPIA looks to Lilly for head of comms

Pharma trade body hires Liam English

- PMLiVE

Shire to file Vyvanse for binge-eating in Q3

Wants to mirror drug’s success as ADHD treatment

- PMLiVE

Pharma’s reputation stays low in 2013

Patient group survey ranks pharma second bottom among healthcare industries

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links